Clinical trial
Study to Evaluate the Amount of Medications That May be Removed From the Body…
NCT00203281 · Sidney Kimmel Cancer Center at Thomas Jefferson University, Other · Withdrawn
Key facts
| NCT number | NCT00203281 |
|---|---|
| Title | Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis |
| Official title | Pharmacokinetic Evaluation of Plasmapheresis in Cross Match Positive or ABO Incompatible Kidney Allograft Recipients |
| Lead sponsor | Sidney Kimmel Cancer Center at Thomas Jefferson University, Other |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Kidney Transplantation, Plasmapheresis |
| Intervention type | Drug, Procedure |
| Interventions | tacrolimus, mycophenolate mofetil, daclizumab, intravenous immune globulin, plasmapheresis |
| Enrollment | 0 |
| Start date | Feb 1, 2003 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 21, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: